2025 Indian drugmaker Dr Reddy's shares slide after Q3 profit miss Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine months ...
Dr. Reddy's Laboratories Ltd. closed 14.80% below its 52-week high of 1,420.20 rupees, which the company reached on August 21st.
Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. Food and Drug Administration, FDA, has accepted a 351(k) Biologic ...
Corient Private Wealth LLC grew its holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 447.3% in the ...
Bank of New York Mellon Corp lifted its holdings in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 271.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 82 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results